1. The reporting person disclaims beneficial ownership of all securities held by his spouse.

2. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 1,747 shares on 7/25/2017 and as to 1,746 shares on 7/25/2018, and becomes exercisable as to 1,747 shares on 7/25/2019.

3. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option became exercisable as to 2,394 shares on 2/16/2018, and becomes exercisable as to 2,393 shares on 2/16/2019 and as to 2,393 shares on 2/16/2020.

4. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 1,037 shares on 02/15/2019, 1,036 shares on 02/15/2020, and 1,037 shares on 02/15/2021.

Steven Scrogham, attorney-in-fact for Brian L. Durkin

10/24/2018

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY
The undersigned constitutes and appoints LAURA J. SCHUMACHER,
KATHLEEN M.S. SCHEIDT, JENNIFER M. LAGUNAS and STEVEN L. SCROGHAM,
and each of them individually, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and
re-substitution, for the undersigned and in the undersigned's name,
place and stead, to prepare and sign any and all Securities and
Exchange Commission ("SEC") Notices of Proposed Sales of Securities
pursuant to Rule 144 under the Securities Act of 1933 on Form 144,
all SEC statements on Forms 3, 4 and 5 as required under Section 16(a)
of the Securities Exchange Act of 1934, including a Form ID and any
other documents necessary to obtain codes and passwords necessary
to make electronic filings, and any amendments or successors to such
forms, and to file the same with all exhibits thereto, and other
documents in connection therewith, with the SEC, granting unto said
attorney-in-fact and agent full power and authority to do and perform
each act and thing requisite, necessary or desirable to be done under
said Rule 144 and Section 16(a), as fully for all intents and purposes
as the undersigned might or could do in person, hereby ratifying and
confirming

all that said attorney-in-fact and agent may lawfully do or
cause to be done by virtue hereof.
A copy of this power of attorney shall be filed with the SEC.
The authorization set forth above shall continue in full force and
effect until the undersigned is no longer required to file Forms 144,
3, 4, or 5 or if earlier, until the undersigned revokes such
authorization by written instructions to the attorney-in-fact.
Date: October 17, 2018
/s/ Brian L. Durkin
Signature of Reporting Person
Brian L. Durkin
Name
AbbVie Inc.
1 N. Waukegan Road
North Chicago, IL 60064